Press "Enter" to skip to content

New patent for Genzyme Corp drug CAPRELSA


Annual Drug Patent Expirations for CAPRELSA
Annual Drug Patent Expirations for CAPRELSA

Caprelsa is a drug marketed by Genzyme Corp
and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug.

This drug has seventy-two patent family members in thirty-eight countries.

The generic ingredient in CAPRELSA is vandetanib. Two suppliers are listed for this compound. Additional details are available on the vandetanib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
or visit

    Do NOT follow this link or you will be banned from the site!